カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界のパクリタキセルAPI市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Paclitaxel API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO4655）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO4655
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のパクリタキセルAPI市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

パクリタキセルAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のパクリタキセルAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

パクリタキセルAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・天然パクリタキセルAPI、半合成パクリタキセルAPI

用途別セグメントは次のように区分されます。
・卵巣がん、子宮頸がん、乳がん、その他

世界のパクリタキセルAPI市場の主要な市場プレーヤーは以下のとおりです。
・Phyton、ScinoPharm、Novasep、Samyang、Polymed、TAPI (Teva)、Fresenius-kabi、Huiang biopharma、Southpharma、Yunnan Hande、Hainan Yew Pharm、Jiangsu Yew Biotechnology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、パクリタキセルAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパクリタキセルAPIメーカーの企業概要、2019年～2022年までのパクリタキセルAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパクリタキセルAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別パクリタキセルAPIの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのパクリタキセルAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのパクリタキセルAPI市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびパクリタキセルAPIの産業チェーンを掲載しています。
・第13、14、15章では、パクリタキセルAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- パクリタキセルAPIの概要
- 種類別分析（2017年vs2021年vs2028年）：天然パクリタキセルAPI、半合成パクリタキセルAPI
- 用途別分析（2017年vs2021年vs2028年）：卵巣がん、子宮頸がん、乳がん、その他
- 世界のパクリタキセルAPI市場規模・予測
- 世界のパクリタキセルAPI生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Phyton、ScinoPharm、Novasep、Samyang、Polymed、TAPI (Teva)、Fresenius-kabi、Huiang biopharma、Southpharma、Yunnan Hande、Hainan Yew Pharm、Jiangsu Yew Biotechnology
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：天然パクリタキセルAPI、半合成パクリタキセルAPI
・用途別分析2017年-2028年：卵巣がん、子宮頸がん、乳がん、その他
・パクリタキセルAPIの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・パクリタキセルAPIのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・パクリタキセルAPIのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パクリタキセルAPIの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・パクリタキセルAPIの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Paclitaxel API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Paclitaxel API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Ovarian Cancer accounting for % of the Paclitaxel API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Natural Paclitaxel API segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Paclitaxel API include Phyton, ScinoPharm, Novasep, Samyang, and Polymed, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Paclitaxel API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Market segment by Application can be divided into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
The key market players for global Paclitaxel API market are listed below:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paclitaxel API, with price, sales, revenue and global market share of Paclitaxel API from 2019 to 2022.
Chapter 3, the Paclitaxel API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Paclitaxel API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Paclitaxel API.
Chapter 13, 14, and 15, to describe Paclitaxel API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Paclitaxel API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Paclitaxel API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Market Analysis by Application
1.3.1 Overview: Global Paclitaxel API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Global Paclitaxel API Market Size & Forecast
1.4.1 Global Paclitaxel API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Paclitaxel API Sales in Volume (2017-2028)
1.4.3 Global Paclitaxel API Price (2017-2028)
1.5 Global Paclitaxel API Production Capacity Analysis
1.5.1 Global Paclitaxel API Total Production Capacity (2017-2028)
1.5.2 Global Paclitaxel API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Paclitaxel API Market Drivers
1.6.2 Paclitaxel API Market Restraints
1.6.3 Paclitaxel API Trends Analysis
2 Manufacturers Profiles
2.1 Phyton
2.1.1 Phyton Details
2.1.2 Phyton Major Business
2.1.3 Phyton Paclitaxel API Product and Services
2.1.4 Phyton Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 ScinoPharm
2.2.1 ScinoPharm Details
2.2.2 ScinoPharm Major Business
2.2.3 ScinoPharm Paclitaxel API Product and Services
2.2.4 ScinoPharm Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novasep
2.3.1 Novasep Details
2.3.2 Novasep Major Business
2.3.3 Novasep Paclitaxel API Product and Services
2.3.4 Novasep Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Samyang
2.4.1 Samyang Details
2.4.2 Samyang Major Business
2.4.3 Samyang Paclitaxel API Product and Services
2.4.4 Samyang Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Polymed
2.5.1 Polymed Details
2.5.2 Polymed Major Business
2.5.3 Polymed Paclitaxel API Product and Services
2.5.4 Polymed Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 TAPI (Teva)
2.6.1 TAPI (Teva) Details
2.6.2 TAPI (Teva) Major Business
2.6.3 TAPI (Teva) Paclitaxel API Product and Services
2.6.4 TAPI (Teva) Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fresenius-kabi
2.7.1 Fresenius-kabi Details
2.7.2 Fresenius-kabi Major Business
2.7.3 Fresenius-kabi Paclitaxel API Product and Services
2.7.4 Fresenius-kabi Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Huiang biopharma
2.8.1 Huiang biopharma Details
2.8.2 Huiang biopharma Major Business
2.8.3 Huiang biopharma Paclitaxel API Product and Services
2.8.4 Huiang biopharma Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Southpharma
2.9.1 Southpharma Details
2.9.2 Southpharma Major Business
2.9.3 Southpharma Paclitaxel API Product and Services
2.9.4 Southpharma Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Yunnan Hande
2.10.1 Yunnan Hande Details
2.10.2 Yunnan Hande Major Business
2.10.3 Yunnan Hande Paclitaxel API Product and Services
2.10.4 Yunnan Hande Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hainan Yew Pharm
2.11.1 Hainan Yew Pharm Details
2.11.2 Hainan Yew Pharm Major Business
2.11.3 Hainan Yew Pharm Paclitaxel API Product and Services
2.11.4 Hainan Yew Pharm Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jiangsu Yew Biotechnology
2.12.1 Jiangsu Yew Biotechnology Details
2.12.2 Jiangsu Yew Biotechnology Major Business
2.12.3 Jiangsu Yew Biotechnology Paclitaxel API Product and Services
2.12.4 Jiangsu Yew Biotechnology Paclitaxel API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Paclitaxel API Breakdown Data by Manufacturer
3.1 Global Paclitaxel API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Paclitaxel API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Paclitaxel API
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel API Manufacturer Market Share in 2021
3.4.2 Top 6 Paclitaxel API Manufacturer Market Share in 2021
3.5 Global Paclitaxel API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Paclitaxel API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Paclitaxel API Market Size by Region
4.1.1 Global Paclitaxel API Sales in Volume by Region (2017-2028)
4.1.2 Global Paclitaxel API Revenue by Region (2017-2028)
4.2 North America Paclitaxel API Revenue (2017-2028)
4.3 Europe Paclitaxel API Revenue (2017-2028)
4.4 Asia-Pacific Paclitaxel API Revenue (2017-2028)
4.5 South America Paclitaxel API Revenue (2017-2028)
4.6 Middle East and Africa Paclitaxel API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Paclitaxel API Sales in Volume by Type (2017-2028)
5.2 Global Paclitaxel API Revenue by Type (2017-2028)
5.3 Global Paclitaxel API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Paclitaxel API Sales in Volume by Application (2017-2028)
6.2 Global Paclitaxel API Revenue by Application (2017-2028)
6.3 Global Paclitaxel API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Paclitaxel API Sales by Type (2017-2028)
7.2 North America Paclitaxel API Sales by Application (2017-2028)
7.3 North America Paclitaxel API Market Size by Country
7.3.1 North America Paclitaxel API Sales in Volume by Country (2017-2028)
7.3.2 North America Paclitaxel API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Paclitaxel API Sales by Type (2017-2028)
8.2 Europe Paclitaxel API Sales by Application (2017-2028)
8.3 Europe Paclitaxel API Market Size by Country
8.3.1 Europe Paclitaxel API Sales in Volume by Country (2017-2028)
8.3.2 Europe Paclitaxel API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Paclitaxel API Sales by Type (2017-2028)
9.2 Asia-Pacific Paclitaxel API Sales by Application (2017-2028)
9.3 Asia-Pacific Paclitaxel API Market Size by Region
9.3.1 Asia-Pacific Paclitaxel API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Paclitaxel API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Paclitaxel API Sales by Type (2017-2028)
10.2 South America Paclitaxel API Sales by Application (2017-2028)
10.3 South America Paclitaxel API Market Size by Country
10.3.1 South America Paclitaxel API Sales in Volume by Country (2017-2028)
10.3.2 South America Paclitaxel API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Paclitaxel API Sales by Type (2017-2028)
11.2 Middle East & Africa Paclitaxel API Sales by Application (2017-2028)
11.3 Middle East & Africa Paclitaxel API Market Size by Country
11.3.1 Middle East & Africa Paclitaxel API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Paclitaxel API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Paclitaxel API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Paclitaxel API
12.3 Paclitaxel API Production Process
12.4 Paclitaxel API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Paclitaxel API Typical Distributors
13.3 Paclitaxel API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Paclitaxel API Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Paclitaxel API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Phyton Basic Information, Manufacturing Base and Competitors
Table 4. Phyton Major Business
Table 5. Phyton Paclitaxel API Product and Services
Table 6. Phyton Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 8. ScinoPharm Major Business
Table 9. ScinoPharm Paclitaxel API Product and Services
Table 10. ScinoPharm Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novasep Basic Information, Manufacturing Base and Competitors
Table 12. Novasep Major Business
Table 13. Novasep Paclitaxel API Product and Services
Table 14. Novasep Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Samyang Basic Information, Manufacturing Base and Competitors
Table 16. Samyang Major Business
Table 17. Samyang Paclitaxel API Product and Services
Table 18. Samyang Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Polymed Basic Information, Manufacturing Base and Competitors
Table 20. Polymed Major Business
Table 21. Polymed Paclitaxel API Product and Services
Table 22. Polymed Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. TAPI (Teva) Basic Information, Manufacturing Base and Competitors
Table 24. TAPI (Teva) Major Business
Table 25. TAPI (Teva) Paclitaxel API Product and Services
Table 26. TAPI (Teva) Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table 28. Fresenius-kabi Major Business
Table 29. Fresenius-kabi Paclitaxel API Product and Services
Table 30. Fresenius-kabi Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Huiang biopharma Basic Information, Manufacturing Base and Competitors
Table 32. Huiang biopharma Major Business
Table 33. Huiang biopharma Paclitaxel API Product and Services
Table 34. Huiang biopharma Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Southpharma Basic Information, Manufacturing Base and Competitors
Table 36. Southpharma Major Business
Table 37. Southpharma Paclitaxel API Product and Services
Table 38. Southpharma Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Yunnan Hande Basic Information, Manufacturing Base and Competitors
Table 40. Yunnan Hande Major Business
Table 41. Yunnan Hande Paclitaxel API Product and Services
Table 42. Yunnan Hande Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hainan Yew Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Hainan Yew Pharm Major Business
Table 45. Hainan Yew Pharm Paclitaxel API Product and Services
Table 46. Hainan Yew Pharm Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Jiangsu Yew Biotechnology Basic Information, Manufacturing Base and Competitors
Table 48. Jiangsu Yew Biotechnology Major Business
Table 49. Jiangsu Yew Biotechnology Paclitaxel API Product and Services
Table 50. Jiangsu Yew Biotechnology Paclitaxel API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Paclitaxel API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 52. Global Paclitaxel API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Paclitaxel API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Paclitaxel API Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 55. Head Office and Paclitaxel API Production Site of Key Manufacturer
Table 56. Paclitaxel API New Entrant and Capacity Expansion Plans
Table 57. Paclitaxel API Mergers & Acquisitions in the Past Five Years
Table 58. Global Paclitaxel API Sales by Region (2017-2022) & (Kiloton)
Table 59. Global Paclitaxel API Sales by Region (2023-2028) & (Kiloton)
Table 60. Global Paclitaxel API Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Paclitaxel API Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Paclitaxel API Sales by Type (2017-2022) & (Kiloton)
Table 63. Global Paclitaxel API Sales by Type (2023-2028) & (Kiloton)
Table 64. Global Paclitaxel API Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Paclitaxel API Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Paclitaxel API Price by Type (2017-2022) & (US$/Ton)
Table 67. Global Paclitaxel API Price by Type (2023-2028) & (US$/Ton)
Table 68. Global Paclitaxel API Sales by Application (2017-2022) & (Kiloton)
Table 69. Global Paclitaxel API Sales by Application (2023-2028) & (Kiloton)
Table 70. Global Paclitaxel API Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Paclitaxel API Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Paclitaxel API Price by Application (2017-2022) & (US$/Ton)
Table 73. Global Paclitaxel API Price by Application (2023-2028) & (US$/Ton)
Table 74. North America Paclitaxel API Sales by Country (2017-2022) & (Kiloton)
Table 75. North America Paclitaxel API Sales by Country (2023-2028) & (Kiloton)
Table 76. North America Paclitaxel API Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Paclitaxel API Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Paclitaxel API Sales by Type (2017-2022) & (Kiloton)
Table 79. North America Paclitaxel API Sales by Type (2023-2028) & (Kiloton)
Table 80. North America Paclitaxel API Sales by Application (2017-2022) & (Kiloton)
Table 81. North America Paclitaxel API Sales by Application (2023-2028) & (Kiloton)
Table 82. Europe Paclitaxel API Sales by Country (2017-2022) & (Kiloton)
Table 83. Europe Paclitaxel API Sales by Country (2023-2028) & (Kiloton)
Table 84. Europe Paclitaxel API Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Paclitaxel API Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Paclitaxel API Sales by Type (2017-2022) & (Kiloton)
Table 87. Europe Paclitaxel API Sales by Type (2023-2028) & (Kiloton)
Table 88. Europe Paclitaxel API Sales by Application (2017-2022) & (Kiloton)
Table 89. Europe Paclitaxel API Sales by Application (2023-2028) & (Kiloton)
Table 90. Asia-Pacific Paclitaxel API Sales by Region (2017-2022) & (Kiloton)
Table 91. Asia-Pacific Paclitaxel API Sales by Region (2023-2028) & (Kiloton)
Table 92. Asia-Pacific Paclitaxel API Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Paclitaxel API Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Paclitaxel API Sales by Type (2017-2022) & (Kiloton)
Table 95. Asia-Pacific Paclitaxel API Sales by Type (2023-2028) & (Kiloton)
Table 96. Asia-Pacific Paclitaxel API Sales by Application (2017-2022) & (Kiloton)
Table 97. Asia-Pacific Paclitaxel API Sales by Application (2023-2028) & (Kiloton)
Table 98. South America Paclitaxel API Sales by Country (2017-2022) & (Kiloton)
Table 99. South America Paclitaxel API Sales by Country (2023-2028) & (Kiloton)
Table 100. South America Paclitaxel API Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Paclitaxel API Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Paclitaxel API Sales by Type (2017-2022) & (Kiloton)
Table 103. South America Paclitaxel API Sales by Type (2023-2028) & (Kiloton)
Table 104. South America Paclitaxel API Sales by Application (2017-2022) & (Kiloton)
Table 105. South America Paclitaxel API Sales by Application (2023-2028) & (Kiloton)
Table 106. Middle East & Africa Paclitaxel API Sales by Region (2017-2022) & (Kiloton)
Table 107. Middle East & Africa Paclitaxel API Sales by Region (2023-2028) & (Kiloton)
Table 108. Middle East & Africa Paclitaxel API Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Paclitaxel API Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Paclitaxel API Sales by Type (2017-2022) & (Kiloton)
Table 111. Middle East & Africa Paclitaxel API Sales by Type (2023-2028) & (Kiloton)
Table 112. Middle East & Africa Paclitaxel API Sales by Application (2017-2022) & (Kiloton)
Table 113. Middle East & Africa Paclitaxel API Sales by Application (2023-2028) & (Kiloton)
Table 114. Paclitaxel API Raw Material
Table 115. Key Manufacturers of Paclitaxel API Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Paclitaxel API Typical Distributors
Table 119. Paclitaxel API Typical Customers
List of Figures
Figure 1. Paclitaxel API Picture
Figure 2. Global Paclitaxel API Revenue Market Share by Type in 2021
Figure 3. Natural Paclitaxel API
Figure 4. Semi-synthetic Paclitaxel API
Figure 5. Global Paclitaxel API Revenue Market Share by Application in 2021
Figure 6. Ovarian Cancer
Figure 7. Cervical Cancer
Figure 8. Breast Cancer
Figure 9. Other
Figure 10. Global Paclitaxel API Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 11. Global Paclitaxel API Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Paclitaxel API Sales (2017-2028) & (Kiloton)
Figure 13. Global Paclitaxel API Price (2017-2028) & (US$/Ton)
Figure 14. Global Paclitaxel API Production Capacity (2017-2028) & (Kiloton)
Figure 15. Global Paclitaxel API Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Paclitaxel API Market Drivers
Figure 17. Paclitaxel API Market Restraints
Figure 18. Paclitaxel API Market Trends
Figure 19. Global Paclitaxel API Sales Market Share by Manufacturer in 2021
Figure 20. Global Paclitaxel API Revenue Market Share by Manufacturer in 2021
Figure 21. Paclitaxel API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Paclitaxel API Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Paclitaxel API Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Paclitaxel API Sales Market Share by Region (2017-2028)
Figure 25. Global Paclitaxel API Revenue Market Share by Region (2017-2028)
Figure 26. North America Paclitaxel API Revenue (2017-2028) & (USD Million)
Figure 27. Europe Paclitaxel API Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Paclitaxel API Revenue (2017-2028) & (USD Million)
Figure 29. South America Paclitaxel API Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Paclitaxel API Revenue (2017-2028) & (USD Million)
Figure 31. Global Paclitaxel API Sales Market Share by Type (2017-2028)
Figure 32. Global Paclitaxel API Revenue Market Share by Type (2017-2028)
Figure 33. Global Paclitaxel API Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Paclitaxel API Sales Market Share by Application (2017-2028)
Figure 35. Global Paclitaxel API Revenue Market Share by Application (2017-2028)
Figure 36. Global Paclitaxel API Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Paclitaxel API Sales Market Share by Type (2017-2028)
Figure 38. North America Paclitaxel API Sales Market Share by Application (2017-2028)
Figure 39. North America Paclitaxel API Sales Market Share by Country (2017-2028)
Figure 40. North America Paclitaxel API Revenue Market Share by Country (2017-2028)
Figure 41. United States Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Paclitaxel API Sales Market Share by Type (2017-2028)
Figure 45. Europe Paclitaxel API Sales Market Share by Application (2017-2028)
Figure 46. Europe Paclitaxel API Sales Market Share by Country (2017-2028)
Figure 47. Europe Paclitaxel API Revenue Market Share by Country (2017-2028)
Figure 48. Germany Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Paclitaxel API Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Paclitaxel API Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Paclitaxel API Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Paclitaxel API Revenue Market Share by Region (2017-2028)
Figure 57. China Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Paclitaxel API Sales Market Share by Type (2017-2028)
Figure 64. South America Paclitaxel API Sales Market Share by Application (2017-2028)
Figure 65. South America Paclitaxel API Sales Market Share by Country (2017-2028)
Figure 66. South America Paclitaxel API Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Paclitaxel API Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Paclitaxel API Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Paclitaxel API Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Paclitaxel API Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Paclitaxel API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Paclitaxel API in 2021
Figure 78. Manufacturing Process Analysis of Paclitaxel API
Figure 79. Paclitaxel API Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のリポソームパクリタキセル市場2022年：市場規模予測（～2028年）
  • 世界のパクリタキセル薬物市場2022年：市場規模予測（～2028年）
  • 世界の過酸素化学物質市場2022年：市場規模予測（～2028年）
  • 世界の金触媒市場2022年：市場規模予測（～2028年）
  • 世界のセルロースフィルム市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO4655 )"世界のパクリタキセルAPI市場2022年：市場規模予測（～2028年）" (英文：Global Paclitaxel API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。